DocDollars

Macrogenics, Inc.

MD · United States · Reporting entity ID 100000961869

Total reported 2019–2025
$26.3M
#265 of 2,960 reporting companies — 0% of all reported industry payments
$46K in general payments across 489 records, plus $26.3M in research funding across 6,264 records.

How it breaks down

General payments $46,374
Research funding $26,276,937

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Macrogenics, Inc. reported $26.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #265 of 2,960 reporting companies. 100% of that was research funding and 0% general payments such as consulting, speaking, food and travel. 489 general payment records and 6,264 research records were filed.

Common questions about Macrogenics, Inc.

How much has Macrogenics, Inc. paid US doctors?

Macrogenics, Inc. reported $26,323,310 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $46,374 in general payments, $26,276,937 in research funding.

How does Macrogenics, Inc. rank among drug and device companies?

It ranks #265 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Macrogenics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.